Holobiome
Latest round
- Seed
Last raised
- Jun 2021
Total raised
- Undisclosed
Investors
- 3
About Holobiome
Based in Massachusetts, US, and co-founded by Philip Strandwitz (CEO), Mike La Fleur (President), and Kim Lewis, Holobiome Inc. operates as a biotechnology research company specializing in solving the complexities of the human gut microbiome. The company is focused on discovering and developing therapies from the human microbiome. The company translates the science of the human microbiome into probiotics and targeted solutions for nervous system disorders and other major whole-body health problems. Holobiome’s product lineup includes probiotics and specialized solutions derived from human gut microbes. Holobiome aims to provide treatments and contribute to improved health outcomes for individuals worldwide.
Who invested in Holobiome
3 investors across 2 rounds
See all investors in Holobiome
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Holobiome
Who invested in Holobiome?
Holobiome has 3 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Holobiome raised?
Holobiome has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Holobiome last raise money?
Holobiome's most recent round on record is a Seed, in Jun 2021.
What does Holobiome do?
Based in Massachusetts, US, and co-founded by Philip Strandwitz (CEO), Mike La Fleur (President), and Kim Lewis, Holobiome Inc.
Where is Holobiome headquartered?
Holobiome is headquartered in Boston, US.
Which VCs invest in companies like Holobiome?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Holobiome's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Holobiome? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.